Rational drug design via intrinsically disordered protein

Area of Science:

• Drug discovery and development
• Molecular biology
• Biochemistry

Background:

• Pharmaceutical research funding has increased, yet drug discovery rates are stagnant or declining.
• Protein-protein interactions are key targets, but developing small molecules to modulate them has been challenging.
• Recent successes indicate potential for routine identification of druggable protein-protein interactions.

Purpose of the Study:

• To highlight the significance of coupled binding and folding in protein-protein signaling.
• To propose a novel strategy for identifying promising protein-protein interaction targets for small molecule modulation.
• To leverage intrinsically disordered proteins for enhanced drug discovery.

Main Methods:

• Analysis of protein-protein signaling mechanisms, emphasizing coupled binding and folding.
• Development of a new strategy based on the properties of intrinsically disordered proteins.
• Identification of specific protein-protein interactions as potential drug targets.

Main Results:

• Coupled binding and folding are crucial for protein-protein signaling interactions.
• Intrinsically disordered proteins present a viable class of targets for small molecule modulation.
• The proposed strategy shows potential for increasing the discovery rate of new chemical entities.

Conclusions:

• A novel strategy utilizing intrinsically disordered proteins can improve the identification of druggable protein-protein interactions.
• This approach may overcome historical limitations in developing small molecules for protein-protein targets.
• The findings offer a promising direction for boosting the efficiency of drug discovery.